Home  /    Quality System

1、Lixin Pharmaceutical was approved by U.S. Food and Drug Administration (FDA) in 2010, and had a review with zero defect in 2015.

2、Lixin Pharmaceutical was approved by European Directorate for the Quality of Medicines (EDQM), European Medicines Agency (EMA) in Oct, 2016.

Hydrochlorothiazide-CEP-certificate Dacarbazine-CEP-certificate Indapamide-CEP-certificate

3、A number of products receive certificates of GMP by China Food and Drug Administration (NMPA)